Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Graham Packham

Showing results (121-130 of 128) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 128 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 14, 2019
Preclinical Evaluation of a Novel SHIP1 Phosphatase Activator for Inhibition of PI3K Signaling in Malignant B CellsElizabeth A Lemm, Beatriz Valle-Argos, Lindsay D Smith, et al.
Blood|August 23, 2021
Insertion of atypical glycans into the tumor antigen-binding site identifies DLBCLs with distinct origin and behaviorGiorgia Chiodin, Joel D Allen, Dean J Bryant, et al.
Blood|March 31, 2021
KDM5 inhibition offers a novel therapeutic strategy for the treatment of KMT2D mutant lymphomasJames Heward, Lola Konali, Annalisa D'Avola, et al.
Leukemia|August 30, 2019
BCR signaling contributes to autophagy regulation in chronic lymphocytic leukemiaLindsay D Smith, Annabel R Minton, Matthew D Blunt, et al.
Oncotarget|May 4, 2017
The histone deacetylase inhibitor, romidepsin, as a potential treatment for pulmonary fibrosisFranco Conforti, Elizabeth R Davies, Claire J Calderwood, et al.
Nature Genetics|December 23, 2015
Recurrent mTORC1-activating RRAGC mutations in follicular lymphomaJessica Okosun, Rachel L Wolfson, Jun Wang, et al.
Nature Genetics|May 28, 2016
Corrigendum: Recurrent mTORC1-activating RRAGC mutations in follicular lymphomaJessica Okosun, Rachel L Wolfson, Jun Wang, et al.
Gut|March 26, 2015
The clinical and biological significance of MIR-224 expression in colorectal cancer metastasisHui Ling, Karen Pickard, Cristina Ivan, et al.
Pageof 13

Showing results (121-130 of 128) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 128 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 14, 2019
Preclinical Evaluation of a Novel SHIP1 Phosphatase Activator for Inhibition of PI3K Signaling in Malignant B CellsElizabeth A Lemm, Beatriz Valle-Argos, Lindsay D Smith, et al.
Blood|August 23, 2021
Insertion of atypical glycans into the tumor antigen-binding site identifies DLBCLs with distinct origin and behaviorGiorgia Chiodin, Joel D Allen, Dean J Bryant, et al.
Blood|March 31, 2021
KDM5 inhibition offers a novel therapeutic strategy for the treatment of KMT2D mutant lymphomasJames Heward, Lola Konali, Annalisa D'Avola, et al.
Leukemia|August 30, 2019
BCR signaling contributes to autophagy regulation in chronic lymphocytic leukemiaLindsay D Smith, Annabel R Minton, Matthew D Blunt, et al.
Oncotarget|May 4, 2017
The histone deacetylase inhibitor, romidepsin, as a potential treatment for pulmonary fibrosisFranco Conforti, Elizabeth R Davies, Claire J Calderwood, et al.
Nature Genetics|December 23, 2015
Recurrent mTORC1-activating RRAGC mutations in follicular lymphomaJessica Okosun, Rachel L Wolfson, Jun Wang, et al.
Nature Genetics|May 28, 2016
Corrigendum: Recurrent mTORC1-activating RRAGC mutations in follicular lymphomaJessica Okosun, Rachel L Wolfson, Jun Wang, et al.
Gut|March 26, 2015
The clinical and biological significance of MIR-224 expression in colorectal cancer metastasisHui Ling, Karen Pickard, Cristina Ivan, et al.
Pageof 13